Anticoccidial Vaccination of Broiler Chickens in Various Management Programmes: Relationship between Oocyst Accumulation in Litter and the Development of Protective Immunity

Paracox anticoccidial vaccine was administered to a 7-day-old flock of commercial broiler breeder stock subsequently reared to point-of-lay in the same house. For comparison, three subgroups of another flock of broiler breeders were also vaccinated with Paracox at 7 days of age, reared to 42 days and then transferred to new litter on another farm until point-of-lay. The first subgroup received no further treatment, but the second and third each received a second vaccination with Paracox, either immediately after transfer to the new litter or 42 days after transfer. Using an Eimeria necatrix model, protective immunity was demonstrated by virulent challenge of samples of birds from all groups by the age of 37–40 days (30–33 days after the first vaccination), and was maintained to at least 122–125 days of age, whether the birds remained on the same litter or were transferred to another farm, and whether they received one or two anticoccidial vaccinations. Therefore, there is no disadvantage in transferring birds onto new litter 35 days after a single Paracox vaccination, nor is there any advantage in giving a second vaccination after such a transfer. Vaccinated birds seeded the new litter with oocysts, despite being clinically immune to coccidiosis. A supplementary laboratory experiment showed that birds vaccinated at 8 days of age passed almost no oocysts after a second vaccination at 43 days of age. This indicated that they were not only protected against clinical coccidiosis, but were almost solidly immune to a homologous infection 5 weeks after a single vaccination. Nevertheless, oocysts appeared in the litter of all four groups of commercial breeders throughout the trial, showing that wild-type heterologous infections occurred whether the birds were transferred to new litter or not, but these did not overwhelm the acquired protective immunity and cause clinical coccidiosis.     

堆型艾美耳球虫子孢子表面抗原基因cSZ1的克隆及序列分析

根据已报道的堆型艾美耳球虫(Eimeria acervulina)子孢子表面抗原基因cSZ1的cDNA序列设计特异性引物,以孢子化12h的E.acervulina广东株卵囊的总RNA为模板,用RT-PCR方法成功克隆了其子孢子表面抗原基因cSZ1(cSZ1(Gd))的cDNA。所克隆cSZ1(Gd)的cDNA全长940bp,其中第3～512位是其阅读框架,共编码170个氨基酸,两端为非编码区。与已报道的cSZ1基因的cDNA序列相比,cSZ1(Gd)有4个位置的核苷酸发生了变异,即原序列中第294、443、569、586位的G、G、G、A在cSZ1(Gd)分别为A、A、A、G,二者核苷酸序列的同源性为99.57％(936/940),其中阅读框架的核苷酸同源性为99.61%(508/510)。比较根据核苷酸序列推导的氨基酸序列,第294位的变异导致了所编码氨基酸由缬氨酸(V)变为异亮氨酸(Ⅰ),而第443位的变异则为无义突变,氨基酸序列的同源性为99.41％(169/170)。     

柔嫩艾美耳球虫棒状体颈部蛋白2基因真核表达载体的构建及在293T细胞中表达

为构建柔嫩艾美耳球虫棒状体颈部蛋白2(Eimeria tenella rhoptry neck protein 2,EtRON2)基因的重组质粒pCAGGS-EtRON2,并转染293T细胞进行表达,以柔嫩艾美耳球虫孢子化卵囊cDNA为模板,经PCR扩增其核心编码区的一部分,将其克隆至pGEM-Teasy载体,构建pGEM-Teasy-EtRON2质粒,双酶切出目的片段后与相应酶切的真核表达载体pCAGGS连接,构建真核表达质粒pCAGGS-EtRON2。该重组质粒经酶切和测序鉴定后转染293T细胞进行表达,分别用免疫印迹和间接免疫荧光鉴定EtRON2基因的表达情况。所构建的真核表达质粒pCAGGS-EtRON2经过双酶切鉴定,可见一条大小约为1172 bp的目的条带,测序结果与GenBank所登录序列完全一致;免疫印迹实验可见大小约为43 kDa的目的蛋白条带,间接免疫荧光实验可以检测到特异性红色荧光。研究结果表明已成功构建了EtRON2的真核表达质粒pCAGGS-EtRON2,并在真核细胞中获得表达,为深入研究EtRON2的生物学功能奠定了基础。     

Sequence and Phylogenetic Analysis of rDNA ITS of Three Eimeria Species in Rabbit

In order to study whether the internal transcribed spacers (ITS) sequence could be used as a molecular marker for the species identification of rabbit coccidian, the rDNA ITS of Eimeria intestinalis, Eimeria flavescens and Eimeria magna were amplified by polymerase chain reaction (PCR), and were cloned into pGEM-T Easy vector subsequently. The positive recombinant plasmids were identified by PCR and then sequenced. By sequence comparison and comparative analysis with the relative sequences of rabbit Eimeria spp. available in GenBank, the results showed that the lengths of Eimeria intestinalis, Eimeria flavescens and Eimeria magna were 1065, 1009 and 1047 bp, respectively, and the sequence homologies with the same species sequences were 99.2%, 99.0% and 94.5%, respectively, while were 55.3% to 82.1% compared with corresponding sequences of other different species sequences. The phylogenetic analysis using software Mega 5.0 showed that all rabbit coccidia clustered together in a clade, which was divided into two sister lineages, corresponding to the presence or absence of oocyst residuum. The result demonstrated ITS could be used as a molecular marker for the species identification of rabbit coccidia.     

ADF-IL-2基因重组卡介苗的构建及免疫保护效果

构建柔嫩艾美尔球虫ADF基因和鸡IL-2基因的重组卡介苗,并研究其免疫保护性.将柔嫩艾美尔球虫的ADF基因和鸡的IL-2基因串联后连接到至穿梭表达载体pMV261和整合表达载体pMV361中电转化卡介苗,制备重组卡介苗pMV261-ADF-IL-2和pMV361-ADF-IL-2,将构建的基因重组卡介苗分别以不同免疫途径接种雏鸡,研究其对柔嫩艾美耳球虫的攻毒的免疫保护效果.结果显示,成功构建重组rBCG pMV261-ADF-IL-2和pMV361-ADF-IL-2,且rBCG滴鼻免疫组的免疫效果较好,其抗球虫指数分别为176.08和172.89.结果表明,构建的基因重组卡介苗pMV261-ADF-IL-2和pMV3 61-ADF-IL-2对柔嫩艾美尔球虫卵囊的攻击具有一定的保护作用.     

柔嫩艾美耳球虫早熟株的初步选育及免疫原性的测定

为选育柔嫩艾美耳球虫的早熟株和了解其免疫原性,本试验通过鸡体的传代培养,初步得到了柔嫩艾美耳球虫早熟株P9。以早熟株免疫雏鸡后,以亲本株P0半数致死量攻毒,以确定其免疫原性。结果表明:P9的潜隐期由P0的141h缩短至131.5h,免疫后攻毒显示该早熟株具有良好的免疫原性。     

柔嫩艾美尔球虫野外株对3种聚醚类离子载体抗生素的敏感性试验

采用鸡体药效试验法测定了柔嫩艾美尔球虫对３种聚醚类离子载体抗生素的敏感性。试验证明，柔嫩艾美尔球虫野外分离株对盐霉素（６６×１０－６）、莫能菌素（１２０×１０－６）和拉沙菌素（１２５×１０－６）产生了耐药性。上述３种药物的抗球虫指数（ＡＣＩ）分别为１４９．３９、１３４．０４和１５６．１１。但这３种药物对柔嫩艾美尔球虫标准株仍然有效     

秦皇岛地区鸡球虫抗药性研究

应用艾维茵肉仔鸡，以最适抗球虫活性百分率（POAA）、病变记分减少率（RLS）和相对卵囊产量（ROP）为判定指标，检测了采自河北省秦皇岛地区的6种艾美耳球虫对8种常用抗球虫药物的敏感性。结果表明：6种混合艾美耳球虫对马杜霉素和盐霉素具有轻度抗药性；对拉沙洛菌素和氨丙淋具有中度抗药性；对球痢灵、克球多和常山酮具有重度抗药性；对地克珠利无抗药性。     

柔嫩艾美耳球虫感染鸡盲肠和脾脏一氧化氮合酶的表达

采用NADPH—d(nicotinamide adenine dinucleotide phosphate—diaphroase)组织化学法观察了雏鸡感染柔嫩艾美耳珠虫(E．tenella)后一氧化氮合酶(N0S)在盲肠和脾脏中的分布与表达情况。试验结果表明，所有正常鸡盲肠粘膜下层和肌层均有较深的着色，根据以往的资料和N0S的表达特性初步判断为神经元型N0S(nNOS)；试验鸡在感染后3～5d，盲肠粘膜上皮和肠腺上皮也有较深的着色，并从感染后7d开始着色减弱；而对照组鸡盲肠粘膜上皮和肠腺上皮以及对照组和试验组的脾脏几乎不着色或着色很浅。试验结果提示，盲肠粘膜上皮和肠腺上皮的着色可能是诱导型N0S(iN0S)表达的结果，而由其产生的N0参与雏鸡球虫感染过程。     

雏鸡实验感染柔嫩艾美尔球虫的病理学研究

１１４只２３日龄无球虫罗斯小公鸡，分为三组，第１和第２每只鸡分别口服１．０８×１０＾５和５．４２×１０＾４个柔嫩艾美尔球虫孢子化卵囊，第３组对照。结果，第１、２组在感染后第４天呈现血便，第５天发性死亡，其死亡率分别为１３．６％５０和５．４％。尸体剖检，盲肠明显肿大，肠壁出血；后期，盲肠萎缩，并出现干酪样肠 芯。病理组织学变化特点，为出血一坏死性或出血一卡地他性盲肠炎，以及出血一卡他性直肠炎。第８天